ArticleNPJ digital medicine2026
Masked autoencoding, generalizable pretraining, and integrated experts for enhanced glioma segmentation.
Article in NPJ digital medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Accurate glioma segmentation is critical for clinical diagnosis and treatment planning, yet remains challenging due to infiltrative tumor growth, heterogeneous imaging protocols, and scarcity of expert annotations. We present MAGPIE, a self-supervised learning framework that combines masked autoencoding, contrastive learning, and sparse mixture of experts to enable accurate glioma segmentation with minimal labeled data. By pretraining on 43,505 unlabeled multi-modal brain MRI scans, MAGPIE learns generalizable representations through a channel-agnostic architecture that handles varying modality configurations without protocol-specific preprocessing. The sparse MoE mechanism with top-2 routing allows specialized expert networks to emerge for different glioma subregions, while deformable attention mechanisms capture infiltrative margins and multi-scale features. Fine-tuning on only 20 labeled cases achieves 60.87% Dice score on BraTS21, a 2.59% absolute improvement over training from scratch, with 70.32% on out-of-distribution data demonstrating robust cross-domain generalization. These results reduce annotation requirements by 95% compared to typical supervised methods, directly addressing the data scarcity bottleneck in rare tumor subtypes and enabling deployment across heterogeneous clinical imaging systems.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.